Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
Dr. Pegram on the Development of Trastuzumab Biosimilars | OncLive
Apr 29, 2019
onclive.com
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses a Comparative Review of Trastuzumab Biosimilar…
Oct 27, 2018
onclive.com
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | OncLive
Dr. Rugo Discusses the Equivalency of Trastuzumab Biosimilars | Onc…
Nov 3, 2018
onclive.com
Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer | OncLive
Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer | Onc…
Dec 19, 2019
onclive.com
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: Updated results of the randomized, phase 3 study DESTINY-Breast03 | OncLive
Trastuzumab deruxtecan versus trastuzumab emtansine in patient…
Dec 22, 2022
onclive.com
Biosimilars
Biosimilars
Mar 26, 2025
gastro.org
LBA1 - Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with high-risk human epidermal growth factor receptor 2–positive (HER2 ) primary breast cancer (BC) with residual invasive disease after neoadjuvant therapy (tx): Interim analysis of DESTINY-Breast05 | OncLive
LBA1 - Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (…
6 months ago
onclive.com
3:50
Herceptin (trastuzumab) for HER2-Positive Breast and Stomach Cancer
44.9K viewsOct 21, 2015
YouTubeOncology Associates
22:53
Trastuzumab deruxtecan (T-DXd) + Pertuzumab FDA Approval in Adv …
4.1K views2 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
FDA Officially Accepts the BLA Resubmission by Sandoz Ag for T…
Jul 15, 2024
marketscreener.com
1:50
Findings of a Biosimilar Trastuzumab Study in Patients Wit…
169 viewsSep 21, 2016
YouTubeTargeted Oncology
1:47
The use of trastuzumab and biosimilars in the treatment of bre…
350 viewsAug 17, 2017
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:45
Trastuzumab-Deruxtecan: A Game-Changer in HER2-Positive Cancer…
3.8K viewsAug 5, 2024
YouTubePharmacology Insights
3:15
What Is Trastuzumab (Herceptin) Used For In HER2-positive Breast …
17 views5 months ago
YouTubeBreast Cancer Support Channel
3:32
ENHERTU: Breakthrough Hope for HER2 Positive Cancers
50.2K viewsSep 2, 2023
YouTubePharma News & Analysis
4:19
ASCO: New Treatment (T-DM1) for HER2-Positive Advanced Breast C…
4.5K viewsJun 3, 2012
YouTubeMDedge: news and insights for busy physicians
5:46
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HE…
3.1K viewsJan 7, 2020
YouTubeecancer
3:04
Trastuzumab Deruxtecan for HER2+ Breast Cancer
8.4K viewsMar 27, 2018
YouTubeOncLive
8:42
Trastuzumab Deruxtecan in HER2+ Breast Cancer
508 viewsJul 7, 2020
YouTubeTargeted Oncology
2:47
Biosimilars: Approval Process
12.3K viewsDec 17, 2021
YouTubeU.S. Food and Drug Administration
0:34
Herceptin: Mechanism of action
52.6K viewsAug 2, 2007
YouTubeCancerQuest-CJ
Switching to Biosimilars in Rheumatic Diseases
Mar 11, 2025
medscape.com
4:01
Trastuzumab deruxtecan: a promising agent for treating HER…
1.7K viewsMay 5, 2021
YouTubeVJOncology
35:22
Is T-DXd + Pertuzumab the New FirstLine Standard? - Drs. Neil Iye…
5.4K views3 months ago
YouTubeCommunity Health Media
7:44
Treatment Options for HER2+ Breast Cancer: A Comprehensive Guide …
15.9K viewsAug 16, 2024
YouTubeYerbba – Breast Cancer
3:43
Evolving Role of Trastuzumab Deruxtecan in HER2+/HER2-Low …
3.7K viewsJan 30, 2020
YouTubeOncLive
0:39
Journey Through Trastuzumab Treatment: Cycle 14 of 18
2.2K views2 months ago
TikTokcheskapulia
1:01
Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer
134 viewsDec 18, 2019
YouTubeOncLive
6:48
Pertuzumab adds 16 months survival to trastuzumab plus chem…
967 viewsNov 11, 2014
YouTubeecancer
See more videos
Static thumbnail place holder